US Stock MarketDetailed Quotes
TMO Thermo Fisher Scientific
- 574.730
- +22.490+4.07%
Close Jul 24 16:00 ET
- 573.300
- -1.430-0.25%
Pre 08:53 ET
219.38BMarket Cap35.65P/E (TTM)
575.250High552.650Low2.86MVolume552.920Open552.240Pre Close1.62BTurnover0.75%Turnover Ratio37.20P/E (Static)381.72MShares603.00552wk High4.63P/B218.88BFloat Cap414.75652wk Low1.48Dividend TTM380.84MShs Float668.138Historical High0.26%Div YieldTTM4.09%Amplitude11.893Historical Low567.966Avg Price1Lot Size
Thermo Fisher Scientific Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Oct 1, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 27.40%1.96B | 71.47%1.25B | -8.17%8.41B | 6.77%3.72B | 24.63%2.41B | 0.79%1.54B | -66.89%729M | -1.70%9.15B | 41.92%3.49B | 1.94B |
| Net income from continuing operations | 14.10%1.55B | 3.02%1.33B | -14.44%5.96B | 2.03%1.61B | 13.15%1.7B | -18.35%1.36B | -41.80%1.29B | -9.94%6.96B | -5.12%1.57B | --1.5B |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -96.61%26M | --0 | --0 |
| Depreciation and amortization | -7.60%790M | -2.68%836M | 0.74%3.41B | -1.06%839M | 1.79%853M | 2.27%855M | 0.00%859M | 30.44%3.38B | 24.16%848M | --838M |
| Deferred tax | -94.51%-354M | -73.29%-253M | -30.65%-1.3B | -403.01%-669M | -16.09%-303M | 30.53%-182M | 56.93%-146M | -53.79%-995M | 30.73%-133M | ---261M |
| Other non cash items | 71.81%256M | -70.17%54M | 16.36%562M | 202.50%121M | -26.97%111M | 156.90%149M | -22.32%181M | 209.62%483M | 211.11%40M | --152M |
| Change In working capital | 69.92%-216M | 48.66%-787M | 50.89%-495M | 62.97%1.77B | 97.55%-9M | 15.43%-718M | -75.20%-1.53B | 33.42%-1.01B | 456.25%1.08B | ---367M |
| -Change in receivables | ---- | ---- | 126.66%209M | ---- | ---- | ---- | ---- | -4,711.76%-784M | ---- | ---- |
| -Change in inventory | ---- | ---- | 172.48%598M | ---- | ---- | ---- | ---- | 22.54%-825M | ---- | ---- |
| -Change in payables and accrued expense | ---- | ---- | -177.16%-500M | ---- | ---- | ---- | ---- | 35.28%648M | ---- | ---- |
| -Change in other working capital | ---- | ---- | -1,606.38%-802M | ---- | ---- | ---- | ---- | 95.03%-47M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 27.27%1.96B | 71.60%1.25B | -8.17%8.41B | 6.77%3.72B | 24.63%2.41B | 0.79%1.54B | -66.89%729M | -1.70%9.15B | 41.92%3.49B | --1.94B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 42.89%-253M | 35.39%-2.03B | -138.17%-5.14B | 28.38%-376M | -116.70%-1.18B | -5.73%-443M | -368.96%-3.14B | 90.16%-2.16B | 97.19%-525M | -545M |
| Net PPE purchase and sale | -1.79%-285M | 24.12%-343M | 37.27%-1.39B | 27.57%-394M | 51.01%-266M | 43.32%-280M | 29.15%-452M | 11.35%-2.22B | 33.66%-544M | ---543M |
| Net business purchase and sale | --0 | --0 | -9,284.62%-3.66B | --0 | -91,000.00%-909M | ---47M | -6,660.00%-2.7B | 99.80%-39M | --0 | --1M |
| Net investment purchase and sale | --27M | ---1.69B | 366.67%70M | ---- | ---- | ---- | --0 | 87.50%15M | ---- | ---- |
| Net other investing changes | 104.31%5M | -50.00%7M | -290.48%-160M | -1,400.00%-52M | -100.00%-6M | -254.67%-116M | 75.00%14M | 300.00%84M | 200.00%4M | ---3M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 42.89%-253M | 35.39%-2.03B | -138.17%-5.14B | 28.38%-376M | -116.70%-1.18B | -5.73%-443M | -368.96%-3.14B | 90.16%-2.16B | 97.19%-525M | ---545M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 92.10%-115M | 29.81%-1.82B | -28.90%-3.62B | -159.72%-1.43B | 1,328.48%1.86B | 23.57%-1.46B | 17.55%-2.59B | -142.70%-2.81B | -71.76%2.39B | -151M |
| Net issuance payments of debt | 99.92%-1M | 139.09%1.21B | -123.70%-155M | -137.44%-1.31B | 197,300.00%1.97B | 27.40%-1.33B | 150.00%504M | -92.66%654M | -59.40%3.49B | ---1M |
| Net common stock issuance | --0 | 0.00%-3B | 0.00%-3B | --0 | --0 | --0 | -50.00%-3B | -50.00%-3B | ---1B | --0 |
| Cash dividends paid | -10.37%-149M | -15.38%-135M | -14.95%-523M | -16.24%-136M | -14.41%-135M | -15.38%-135M | -13.59%-117M | -15.19%-455M | -13.59%-117M | ---118M |
| Net other financing activities | 775.00%35M | 445.00%109M | 722.22%56M | -30.00%14M | 156.25%18M | -89.19%4M | 158.82%20M | -113.85%-9M | -74.68%20M | ---32M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 92.10%-115M | 29.77%-1.82B | -28.90%-3.62B | -159.72%-1.43B | 1,328.48%1.86B | 23.57%-1.46B | 17.55%-2.59B | -142.70%-2.81B | -71.76%2.39B | ---151M |
| Net cash flow | ||||||||||
| Beginning cash position | 57.69%5.52B | -5.15%8.1B | 90.09%8.54B | 110.22%6.17B | 65.51%3.15B | 25.94%3.5B | 90.09%8.54B | -56.55%4.49B | -75.65%2.93B | --1.91B |
| Current changes in cash | 543.73%1.59B | 48.06%-2.6B | -108.55%-358M | -64.15%1.92B | 148.83%3.09B | 54.90%-359M | -210.35%-5.01B | 169.30%4.19B | 168.91%5.35B | --1.24B |
| Effect of exchange rate changes | -225.00%-15M | 170.97%22M | 41.01%-82M | -96.00%10M | 65.57%-73M | 115.38%12M | 68.69%-31M | -171.65%-139M | 18.48%250M | ---212M |
| End cash Position | 125.09%7.1B | 57.69%5.52B | -5.15%8.1B | -5.15%8.1B | 110.22%6.17B | 65.51%3.15B | 25.94%3.5B | 90.09%8.54B | 90.09%8.54B | --2.93B |
| Free cash flow | 32.09%1.66B | 233.58%904M | 0.23%6.93B | 12.97%3.32B | 49.78%2.08B | 22.90%1.26B | -82.65%271M | 1.80%6.91B | 80.63%2.94B | --1.39B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
